Jobs
-
Job Title: Senior Scientist, Formulations Location: Florida, Lupin USA Inc. Function: R&D Reports to: Director of Pharmaceutical Development Summary Independently conducts standard and advanced laboratory activities including evaluation and selection of raw materials, formulation development… Read more . . .
-
Job Title: Principal Scientist, Formulations Location: Florida, Lupin USA Inc. Function: R&D Reports to: Director, Pharmaceutical Development Summary Supervise standard and advanced laboratory activities including evaluation and selection of raw materials and formulation development of… Read more . . .
-
Job Title: Fellow, Research Location: Florida, Lupin USA Inc. Function: R&D Reports to: Senior Director, Inhalation R&D Summary Provides technical leadership in Research activities within Lupin Respiratory R&D Florida, functions as analytical and product characterization… Read more . . .
-
Job Title: Scientist I, Pharmaceutical Development Location: Florida, Lupin USA Inc. Function: R&D Reports to: Manager, Pharmaceutical Development Summary Conducts routine and non-routine laboratory activities following with minimal supervision. Assures that Quality standards are met.… Read more . . .
-
Submit podium presentation proposals by February 28, 2014 at http://www.rddonline.com/rdd/speaker_reg.php?id=10 Workshop proposals should be submitted to http://www.rddonline.com/rdd/workshop_reg.php?id=10&sid=6 by February 14. Read more . . .
-
Rexam has announced the decision to sell all three divisions of its Healthcare business: Pharmaceutical Devices, Prescription Retail Packaging and Closures & Containers. Montagu Private Equity has made an offer of $805 million for the… Read more . . .
-
Sanofi US consumer healthcare division Chattem has announced that Nasacort Allergy 24HR Nasal Spray is now available over the counter in the United States. The FDA approved the triamcinolone acetonide nasal spray as an OTC… Read more . . .
-
Bill Doub is Lead Chemist, R&D in the FDA’s Division of Pharmaceutical Analysis, which is part of the Office of Pharmaceutical Science in the Center for Drug Evaluation and Research (CDER). . . . Read… Read more . . .
-
Civitas Therapeutics has announced that former Sunovion CEO Mark Iwicki will succeed Glenn Batchelder as President and Chief Executive Officer. Iwicki was most recently CEO of Blend Therapeutics. According to Civitas, which is developing inhaled… Read more . . .
-
According to Avanir Pharmaceuticals, the company has submitted a 505(b)(2) New Drug Application (NDA) for its AVP-825 intranasal dry powder sumatriptan for the treatment of migraine to the FDA. Avanir acquired the North American license… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
December 9-December 11: DDL 2026, Edinburgh, Scotland
April 27-30: RDD Europe 2027, Antibes, France
May 12-13: USP Joint Workshop: Quality and Product Performance Testing of Orally Inhaled and Nasal Drug Products, Rockville, MD, USA
June 30: RespireX 2027, Boston, MA, USA